Monday, October 13, 2025
Home Authors Posts by Ogkologos

Ogkologos

4035 POSTS 0 COMMENTS

Clinical Benefit of Pembrolizumab in Patients with Previously Treated Advanced Clear...

Ogkologos -
0

Combining Daratumumab with VRd Improves Outcomes in Patients with Transplant-Ineligible or...

Ogkologos -
0

EMA Recommends Extension of Therapeutic Indications for Lisocabtagene Maraleucel

Ogkologos -
0

FDA Approves Datopotamab Deruxtecan-dlnk for Unresectable or Metastatic, Hormone Receptor-positive, HER2-negative...

Ogkologos -
0

Can AI Help Predict Which Cancer Patients Should Be Treated with...

Ogkologos -
0

Strong Independent Association of TILs with OS for Patients with ERBB2-positive...

Ogkologos -
0

Acalabrutinib-Venetoclax With or Without Obinutuzumab Significantly Prolongs PFS in Fit Patients...

Ogkologos -
0

ESMO Targeted Anticancer Therapies Congress 2025, Paris, France, 3-5 March

Ogkologos -
0

Neoadjuvant Nivolumab Plus Ipilimumab Shows Trend Towards Long-Term Clinical Benefit versus...

Ogkologos -
0

Abnormal Results from Prenatal Blood Test Could Point to Cancer in...

Ogkologos -
0
1...202122...404Page 21 of 404

MOST POPULAR

Load more

HOT NEWS

Follow us on Instagram @ogkologos

Το πρώτο ολοκληρωμένο portal για τον καρκίνο. Ενημερωθείτε για τον καρκίνο, καθώς και για τις τελευταίες εξελίξεις.
Contact us: info@ogkologos.com

POPULAR POSTS

POPULAR CATEGORY

Copyright © 2023 Ogkologos.com